Large gap with delayed quotes
Analysis date: 18.09.2026
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 08.09.2026.
Quality
Very weak
Very weak
One star since 15.09.2026.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 15.09.2026 at a price of 30.16.
Evaluation
Strongly undervalued
Strongly undervalued
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 08.09.2026.
4wk Rel Perf
-12.74%
-12.74%
The four-week dividend-adjusted underperformance versus STOXX600 is 12.74%.
Risk
High
High
The stock has been on the high-sensitivity level since 28.11.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -1.51%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 4.96%.
Mkt Cap in $bn
1.73
1.73
With a market capitalization <$2bn, NANOBIOTIX SA is considered a small-cap stock.
G/PE Ratio
1.22
1.22
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
73.06
73.06
The estimated PE is for the year 2028.
LT Growth
89.39%
89.39%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
4
4
Over the last seven weeks, an average of 4 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
85
85
For 1% of index variation, the stock varies on average by 0.85%.
Correlation
0.11
0.11
Stock movements are totally independent of index variations.
Value at Risk
14.96
14.96
The value at risk is estimated at EUR 14.96. The risk is therefore 50.10%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
22.07.2014
22.07.2014